It has been previously reported that activators or blockers of thrombin-activated PAR-1 evoke a decrease and increase in blood pressure in healthy animals, respectively [28], whereas the blockade of PAR-1 in renin-overexpressing mice reduces hypertension [29]. The gene discussed is F2R; the disease is hypertensive disorder.